Digital Therapeutics Transforming Global Orthopaedic Care
Global, Tuesday, 7 October 2025.
Musculoskeletal digital therapeutics are revolutionizing orthopaedic care, addressing challenges in rehabilitation for over 1.7 billion affected individuals, enhancing patient outcomes through AI-driven solutions.
The Rise of Digital Therapeutics in Orthopaedics
Digital therapeutics (DTx) are reshaping orthopaedic care by addressing the long-standing challenges of accessibility, adherence, and personalization in rehabilitation. Traditional methods often fail to meet the needs of the 1.7 billion individuals affected by musculoskeletal disorders (MSDs) globally, which are the leading cause of disability worldwide [1]. DTx, encompassing AI-driven motion analysis, wearable sensors, and tele-rehabilitation platforms, offer innovative solutions regulated as medical devices to improve chronic disease management [1].
Enabling Technologies and Clinical Applications
Core technologies such as artificial intelligence, cloud-based ecosystems, and wearable sensors drive the effectiveness of digital therapeutics in musculoskeletal care. These technologies enable precise motion analysis and personalized rehabilitation plans, greatly enhancing patient adherence and outcomes [1]. Clinical applications span various orthopaedic subspecialties, including spine, upper and lower extremities, sports injuries, and trauma. The integration of these technologies is supported by early clinical evidence showing significant improvements in functional outcomes and cost-effectiveness [1][2].
Economic and Regulatory Considerations
As the digital musculoskeletal care market continues to grow, with projections indicating robust development from 2025 to 2032, economic and regulatory frameworks play pivotal roles in shaping its trajectory. Major players such as Hinge Health, Kaia Health, and Physitrack are leading innovation in this sector, while global regulatory bodies work to establish standards for DTx implementation [2]. These efforts aim to ensure safety, efficacy, and integration into existing healthcare systems, addressing economic considerations and implementation challenges [1].
Future Directions and Global Impact
Looking ahead, advancements in digital twin technologies, predictive analytics, and the integration of precision orthopaedics are poised to further revolutionize musculoskeletal care. The potential of DTx to bridge global rehabilitation access gaps and reduce healthcare costs is immense [1]. With the Telerehabilitation Systems Market projected to reach USD 1.35 billion by 2034, the integration of virtual reality, AI, and motion tracking in rehabilitation is set to enhance patient engagement and adherence significantly [3]. The COVID-19 pandemic has accelerated the adoption of these technologies, highlighting their viability and convenience in modern healthcare [3].